1202 Mrv0541 02231215192D 12 12 0 0 1 0 999 V2000 4.5311 0.7543 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.6500 -0.3006 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.0791 0.5244 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.3645 -1.5382 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.4115 1.0093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0791 -0.3006 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 2.6666 1.7939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.4916 1.7939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.7465 1.0093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.7935 -0.7132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3645 -0.7132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.7935 -1.5382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 9 2 0 0 0 0 2 11 2 0 0 0 0 3 5 1 0 0 0 0 3 6 1 0 0 0 0 3 9 1 0 0 0 0 4 11 1 0 0 0 0 5 7 1 0 0 0 0 6 10 1 6 0 0 0 6 11 1 0 0 0 0 7 8 1 0 0 0 0 8 9 1 0 0 0 0 10 12 1 0 0 0 0 M END > DB01202 > approved; investigational > Levetiracetam > Levetiracetam [INN]; Levetiracetamum [INN-Latin]; Levitiracetam > Keppra > C8H14N2O2 > 170.209 > 170.105527702 > (2R)-2-(2-oxopyrrolidin-1-yl)butanamide > InChI=1S/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12)/t6-/m1/s1 > InChIKey=HPHUVLMMVZITSG-ZCFIWIBFSA-N > CC[C@@H](N1CCCC1=O)C(N)=O > 2 > 1 > -0.64 > -0.59 > 0.24 > 17.78 > 63.4 > 44.08 > 3 > 2.98e+02 g/l $$$$